Aktiesnakken — August 2010
-
mht. ASR
-
det var bare en beskrivlese af hvordan et diagnostisk selskab kunne "omgås" FDA
-
-
bl.a. Home brew, og så ASR
-
Yet another route is to sell one or more of
the components of their diagnostic to testing
laboratories as analyte-specific reagents
(ASRs), thus enabling early market penetration
and enhancing early adoption of their
technology. -
home brew, selvom Mayo kun bruger testen in house, så må de gerne distribuere den, når de foretager den godkendelse
-
he he, Ebdrups, alle kneb gælder med de konkurrenter, se bare Abbott, de bruger også ufine tricks
-
tror bare at de hysteriske sendte den for langt ned i sidste uge, og det så er en normal korrektion,.
-
ingne særlig årsag ihvertfald, måske lidt med AU, at de opjusterer kortsigtet kursmål, fra 8 til 10, men er lidt i tvivl
-
om hvor meget magt de efterhånden har over aktierne, den var større førhen
-
er fuldstændig enig
-
jeg bruger Euroinvestor en bette kun, men kriver sjældent derovre, der ender ltid i ævl og bævl
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind